Friday, January 18, 2013

• Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunityat Seeking Alpha (Fri, Jan 18)
• YM Biosciences says ISS, Glass Lewis endorse Gilead dealat theflyonthewall.com (Fri, Jan 18)

Wednesday, January 9, 2013

• JPMorgan Healthcare Conference Highlights: Incyteat Motley Fool (Wed, Jan 9)

Friday, December 28, 2012

• Canadian Biotech Isn't Dead; Following The Money To Undervalued Equitiesat Seeking Alpha (Fri, Dec 28)

Friday, December 21, 2012

• Gilead A Strong Buy On New HIV Treatmentsat Motley Fool (Fri, Dec 21)

Monday, December 17, 2012

• This Week in Biotechat Motley Fool (Mon, Dec 17)

Sunday, December 16, 2012

• 1 Buyout Bolstering Big Biotechat Motley Fool (Sun, Dec 16)

Friday, December 14, 2012

• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Fri, Dec 14)
• A Not-So-Bad Acquisition By Gileadat Seeking Alpha (Fri, Dec 14)

Thursday, December 13, 2012

• Profit Off the Growth and Reform of Health Careat Motley Fool (Thu, Dec 13)
• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Thu, Dec 13)
• Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Thu, Dec 13)
• Gilead to Buy YM BioSciencesZacks (Thu, Dec 13)

Wednesday, December 12, 2012

• Gilead Needs to Ask, "YMI Buying This Biotech?"at Motley Fool (Wed, Dec 12)
• Gilead Sciences to buy YM Biosciences for $510MAP (Wed, Dec 12)
• Gilead adds to cancer franchise with planned $510M acquisitionat bizjournals.com (Wed, Dec 12)
• Gilead Makes Another Bet on Cancer, Incyte Shares Fallat Minyanville (Wed, Dec 12)
• YM Biosciences downgraded to Neutral from Buy at Roth Capitaltheflyonthewall.com (Wed, Dec 12)
• YM BioSciences's Strange Journey Comes To A Strange Conclusionat Seeking Alpha (Wed, Dec 12)
• Stock Watch Wednesday, 12 Decemberat Seeking Alpha (Wed, Dec 12)
• Gilead Acquiring YM Biosciences For Cancer Drugat Investor's Business Daily (Wed, Dec 12)
• Gilead Sciences to buy YM BioSciences in $510M dealat bizjournals.com (Wed, Dec 12)
• The Long YM Bio Nightmare Has Ended -- Happily.at TheStreet (Wed, Dec 12)
• Gilead to acquire YM Biosciences for $2.95 per share in cashtheflyonthewall.com (Wed, Dec 12)
• Gilead Sciences to Acquire YM BioSciencesBusiness Wire (Wed, Dec 12)

Add YMI News to My Yahoo!